Recent studies have demonstrated that STS had potential to promote the SIRT1 expression, thereby providing relief for various diseases, including non-alcoholic fatty liver disease, chronic obstructive pulmonary disease, and cardiovascular disease [20, 34, 69]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.